Combination surgery for erectile dysfunction and male incontinence.

Area of Science:

• Urology
• Oncology
• Sexual Medicine

Background:

• Radical therapy for pelvic malignancy increasingly focuses on oncological clearance and functional outcomes.
• Urogenital dysfunction, including stress urinary incontinence and erectile dysfunction, significantly impacts patients' quality of life post-treatment.
• Assessing and managing these functional deficits is crucial for comprehensive patient care.

Purpose of the Study:

• To review the prevalence of urogenital dysfunction after pelvic malignancy treatment.
• To explore available therapeutic options for managing sexual and urinary impairments.
• To evaluate the efficacy of combination therapies for erectile dysfunction and stress urinary incontinence.

Main Methods:

• Literature review of studies on pelvic malignancy treatment outcomes.
• Analysis of clinical and diagnostic assessments for urogenital dysfunction severity.
• Evaluation of evidence for combination surgical approaches.

Main Results:

• Urogenital dysfunction is a common adverse outcome following radical pelvic interventions.
• Combination surgery for erectile dysfunction and stress urinary incontinence demonstrates effectiveness and durability.
• Patient preference and severity of outcomes guide treatment selection.

Conclusions:

• Achieving oncological clearance alongside acceptable sexual and urinary function is paramount in pelvic malignancy treatment.
• Combination surgery offers a definitive solution for men experiencing both erectile dysfunction and stress urinary incontinence.
• Further research and careful patient assessment are vital for optimizing functional outcomes and quality of life.